Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2023-11-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Aprogen' (에이프로젠) for the period ending September 30, 2023. It contains detailed corporate information, history, capital changes, and management structure, which are standard components of a formal quarterly financial report filed with the Korean financial authorities (FSS/KRX). It is not an announcement or a summary, but the full report itself. 9M 2023
2023-11-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by a major shareholder (G-Base Inc.) in Aprogen. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant share ownership levels.
2023-11-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details changes in share ownership by a major shareholder (G-Base) and related parties in the company Aprogen. This type of filing is a mandatory regulatory disclosure regarding significant ownership thresholds and does not fit into categories like Annual Reports, Earnings Releases, or Proxy Statements. Therefore, it is classified as a Regulatory Filing (RNS).
2023-11-10 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Aprogen. It details specific transactions (buy/sell) by major shareholders and related parties, including changes in share counts and ownership percentages. This type of filing is a standard regulatory disclosure regarding significant shareholding changes and insider/major shareholder activity, which falls under the 'Major Shareholding Notification' category.
2023-11-10 Korean
투자판단관련주요경영사항(AP063(허셉틴 바이오시밀러) 유럽의약품청(EMA) 임상3상 시험계획 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the submission of a Phase 3 clinical trial application to the European Medicines Agency (EMA). This type of disclosure is a standard regulatory announcement for material corporate events. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2023-10-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when a major shareholder or executive changes their stake in a company. Since the document details the change in share ownership by a major shareholder (G-Base Inc.) in the company Aprogen, it falls under the category of Major Shareholding Notification (MRQ).
2023-10-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.